Drug Shortage Report for VINBLASTINE SULPHATE INJECTION

Last updated on 2025-02-03 History
Report ID 245304
Drug Identification Number 02401460
Brand name VINBLASTINE SULPHATE INJECTION
Common or Proper name VINBLASTINE SULFATE INJECTION 10MG/10ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VINBLASTINE SULFATE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10ML
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-02-01
Actual start date 2025-02-02
Estimated end date 2025-04-01
Actual end date
Shortage status Actual shortage
Updated date 2025-02-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-02-03 French Compare
v8 2025-02-03 English Compare
v7 2025-02-02 English Compare
v6 2025-01-17 French Compare
v5 2025-01-17 English Compare
v4 2024-12-20 French Compare
v3 2024-12-20 English Compare
v2 2024-12-10 French Compare
v1 2024-12-10 English Compare

Showing 1 to 9 of 9